Loading...
Therapeutic vaccine to cure large mouse hepatocellular carcinomas
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide with limited therapeutic options. Here we report the development of a therapeutic vaccination regimen (shortened as ‘TheraVac’) consisting of intratumoral delivery of high-mobility group nucleosome-binding protein 1 (HMG...
Saved in:
| Published in: | Oncotarget |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Impact Journals LLC
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5581012/ https://ncbi.nlm.nih.gov/pubmed/28881713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19367 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|